search

Inaugurated recently in June 2021, MeluXina is holding its own among the world’s high performance computers (HPCs). The young supercomputer has already received top marks by ranking organisation TOP500, which places it 1st in the EU and 4th in the world for its energy efficiency.

Exceptional energy efficiency

MeluXina’s system is water-cooled, which removes the high operational costs of air-cooled systems and, in parallel, reduces the energy footprint. MeluXina relies on the latest AMD EPYC processors and NVidia A100 GPUs to achieve remarkable efficiency in terms of performance to power consumption ratio (26.957 gigaflops/watt).

We are proud to lead the way in European green HPC technology.

“We are proud to lead the way in European green HPC technology,” comments Anders Dam Jensen, Executive Director of the EU initiative EuroHPC Joint Undertaking. “MeluXina confirms that the next generation of supercomputers will need to harness energy efficient solutions and contribute to environmental targets while providing world-class supercomputing capabilities.”

Most powerful HPCs

TOP500 also ranks MeluXina as the 10th most powerful HPC in the EU and the 36th most powerful one in the world. “We are delighted with the results: they show the fruit of years of planning and now implementation of the vision of what MeluXina should be,” says Valentin Plugaru, Chief Technology Officer of LuxProvide that manages the supercomputer.

MeluXina will provide a robust platform for science and industry for years to come.

Unlike most HPCs that are pure research infrastructures, 65% of MeluXina’s capacity will be available for start-ups, SMEs and large companies. “The system has been built on an efficient platform and is meant to serve a large variety of complex, data-driven computational workloads,” explains Mr Plugaru. “Based on the Modular Supercomputing Architecture, its forward-looking design responds to the convergence of simulation, modelling, data analytics and artificial intelligence, and enables simulation driven by predictive analytics. MeluXina will provide a robust platform for science and industry for years to come.”

Photo credit: LuxProvide

Interested in benefiting from Luxembourg's HPC?

Read more

Rendering data actionable to drive healthcare innovation: ITTM

06-12-2023

Health data is proving to be a formidable catalyst for change. However, the mere accumulation of data does not guarantee transformative outcomes. The essence lies in making data actionable – a challenge that Luxembourg medical data specialist ITTM has taken up.
Read more

Entering the European market with ease

29-11-2023

In recent years, Luxembourg has emerged as a dynamic hub for innovation, boasting a robust ecosystem that encompasses a multitude of incubators, accelerators, specialised agencies, investors, and innovation hubs. This thriving ecosystem has played a pivotal role in nurturing and propelling numerous successful enterprises across diverse industries onto the global stage. Top executives leading some of Luxembourg’s key structures explain what the ecosystem offers and why this might just be the smartest and most cost-effective way for a soft-landing and to gain a foothold in foreign markets.
Read more

Pioneering “gamified neuroscience” for brain disorders

27-11-2023

Luxembourg-based company Myelin-H is developing a revolutionary software technology for the remote monitoring and management of neurological disorders. The company’s CEO, Zied Tayeb, sheds light on the company’s mission to make a difference and how a personal story sparked the conception of his startup.
Read more

Accessing the European healthtech market

22-11-2023

Healthtech solutions are subject to rather complex regulatory requirements guaranteeing health standards and protection in the EU. Luxembourg’s national innovation agency Luxinnovation manages a range of initiatives aimed at supporting healthtech companies from strategy development to European market access.
Read more

On the road to personalised medicine

20-11-2023

In 2008, the Luxembourg government launched its Sciences and Health Technologies Action Plan to diversify its economy, nurture health technology innovation and stimulate the shift towards personalised medicine. Fifteen years later, the country is home to internationally renowned biomedical research centres and a growing community of healthtech companies focusing, in particular, on digital health, digital medical devices and in vitro diagnostics.
Read more

Resources all news

Fermer